Scientists have identified a promising target for treatment of a devastating autoimmune disease affecting the brain.
No standard treatments for the sometimes deadly disorder have been developed, but that may change due to the newly published ...
The images showed that nearly all the antibodies bind to a single domain of the receptor, providing a viable target for novel therapeutics.
Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease Study ...
Scientists have identified a promising target for treatment of a devasting autoimmune disease affecting the brain.
Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...
Viruses. Current Pharmaceutical Design, 25(43),4579-88. 7. Wang, H.* (2022). COVID-19, Anti-NMDA Receptor Encephalitis and MicroRNA. Fronters in Immunology, 13:825103.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback